Researchers evaluated metabolically stabilized analogs of angiotensin IV in animal models to assess their potential effects on cognition and dementia-related outcomes. The study found that these modified compounds demonstrated procognitive properties in the tested animal models. This is animal model evidence and does not establish efficacy or safety in human populations.
For your business
Metabolically stabilized Dihexa analogs show procognitive effects in animal models; human translation remains unestablished.
Read more on The Journal of pharmacology and experimental therapeutics →